Conversely, for healthy controls, non-methylation was more dominant with 42 (84%) compared to BLCA patients with 16 (32%) showcasing non-methylation for the APC promoter gene (Figure 1). The gene discussed is APC; the disease is bladder transitional cell carcinoma.